EUVIMEDEUVIMED entdecken
Open Access

SON is an essential m6A target for hematopoietic stem cell fate

Hanzhi Luo, Mariela Cortés-López, Cyrus L Tam, Michael Xiao, Isaac Wakiro, Karen L Chu, Aspen Pierson, Mandy Chan, Kathryn Chang, Xuejing Yang, Daniel Fecko, Grace Han und 4 weitere

Cell Stem Cell · 2023

DOI: 10.1016/j.stem.2023.11.006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2023. Verfasst von Hanzhi Luo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematolog…. Hauptthemen laut MEDLINE: Hematopoietic Stem Cells, Inflammation, DNA-Binding Proteins, RNA Methylation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCI NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem CellsInflammationDNA-Binding ProteinsRNA MethylationAnimalsHumansMiceCell DifferentiationMethylationMethyltransferasesRNA, MessengerMinor Histocompatibility AntigensNuclear ProteinsAdenosine

Stichwörter der Autor:innen

RNA binding proteinsRNA methylationRNA modificationsSONcell fatedifferentiationhematopoietic stem cellsinflammationnuclear specklesstem cells

Substanzen

MethyltransferasesRNA, MessengerDNA-Binding ProteinsMETTL3 protein, humanSON protein, humanMinor Histocompatibility AntigensSon protein, mouseNuclear ProteinsN-methyladenosineAdenosine

Autor:innen und Institutionen

  • Molecular Pharmacology Program, Center for Cell Engineering, Center for Stem Cell Biology, Center for Experimental Therapeutics, Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY,…
  • New York Genome Center, New York, NY, USA; Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Institute of Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Computational and Systems Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA; Tri-Institutional Training Program in Computational Biology and Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Department of Pathology, Division of Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL, USA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, U…

Förderung

  • NHGRI NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS
  • NIDDK NIH HHS
  • AbbVie
  • Memorial Sloan-Kettering Cancer Center
  • New York State Stem Cell Science
  • NIDDK

Zitieren

APA

Luo, H., Cortés-López, M., Tam, C. L., Xiao, M., Wakiro, I., Chu, K. L., Pierson, A., Chan, M., Chang, K., Yang, X., Fecko, D., Han, G., Ahn, E. E., Morris, Q. D., Landau, D. A., & Kharas, M. G. (2023). SON is an essential m6A target for hematopoietic stem cell fate. Cell Stem Cell. https://doi.org/10.1016/j.stem.2023.11.006

Vancouver

Luo H, Cortés-López M, Tam CL, Xiao M, Wakiro I, Chu KL, et al. SON is an essential m6A target for hematopoietic stem cell fate. Cell Stem Cell. 2023. doi:10.1016/j.stem.2023.11.006

BibTeX
@article{Luo2023,
  author = {Luo, Hanzhi and Cortés-López, Mariela and Tam, Cyrus L and Xiao, Michael and Wakiro, Isaac and Chu, Karen L and Pierson, Aspen and Chan, Mandy and Chang, Kathryn and Yang, Xuejing and Fecko, Daniel and Han, Grace and Ahn, Eun-Young Erin and Morris, Quaid D and Landau, Dan A and Kharas, Michael G},
  title = {SON is an essential m6A target for hematopoietic stem cell fate},
  journal = {Cell Stem Cell},
  year = {2023},
  doi = {10.1016/j.stem.2023.11.006}
}
Kostenlos starten →